Skip to main content

Table 1 Clinical features of TNBC and non-TNBC patients

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

 

Non-TNBC

TNBC

P

Survival (months, median)

84.8

65.85

0.006#

Tumor size (units, median)

22

25

0.153#

Grade

  

<0.001*

 1

103

3

 

 2

475

27

 3

462

165

Unknown

55

9

Stage

  

0.425

 0–2

863

155

 

 3–4

88

22

Unknown

144

27

Lymph nodes

  

0.096

 No

606

100

 

 Yes

489

104

Distal metastasis

  

0.578

 No

799

145

 

 Yes

296

59

  1. TNBC triple negative breast cancer
  2. #Student’s t test
  3. *Chi-square test